Evidence map›Paper›PMID 37724196›Full record

ArticleCureus2023

Delayed Presentation of Antipsychotic Withdrawal Tardive Dyskinesia: A Case Report.

Siddhant Solanki, Lakshmi Sai Deepak Reddy Velugoti

Abstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Siddhant SolankiDepartment of Medicine, Tbilisi State Medical University, Tbilisi, GEO.
Lakshmi Sai Deepak Reddy VelugotiDepartment of Research, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tardive dyskinesia (TD) is an iatrogenic cause that occurs after prolonged use of antipsychotic and other dopamine-related medications and is described as repetitive, involuntary movement of muscles in the body. This case report focuses on an 80-year-old man who presented with a medical history encompassing dementia, bilateral blindness, glaucoma, hearing loss, hypertension, and hypercholesterolemia. He visited the clinic with a complaint of experiencing visual hallucinations. Investigations, including a CT head and EEG, revealed normal results, and Risperidone was prescribed. In the subsequent visit, Risperidone was prescribed again with Quetiapine and then replaced with valproate because of no change in symptoms and medication non-adherence. Over time, the patient felt better but started to have orofacial tremors after three months of discontinuing antipsychotic medications. For the orofacial tremors, the patient was prescribed Duetetrabenazine and asked for a follow-up visit. Early recognition and treatment of TD would be beneficial for these patients, and when prescribing, it's important to be aware that they may lead to delayed onset of TD.

Indexed as

#anti-psychotics#dopamine receptor blocking agent#risperidone#tardive dyskinesia#withdrawal dyskinesia

Identifiers

PMID37724196
PMCPMC10505356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.